Melatonin and cell death: differential actions on apoptosis in normal and cancer cells

被引:260
作者
Sainz, RM
Mayo, JC
Rodriguez, C
Tan, DX
Lopez-Burillo, S
Reiter, RJ
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
[2] Univ Oviedo, Fac Med, Inst Oncol, Dept Morfol & Biol Celular, E-33006 Oviedo, Spain
关键词
melatonin; apoptosis; free radicals; neuroprotection; immune system; cancer cells;
D O I
10.1007/s00018-003-2319-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melatonin is a natural compound synthesized by a variety of organs. It has been shown to function as a cell-protective agent. Since 1994, when the first paper was published documenting the role of melatonin in apoptosis, the number of reports in this area has increased rapidly. Much of the research conducted falls into three major categories: first, the role of melatonin in inhibiting apoptosis in immune cells; second, the role of melatonin in preventing neuronal apoptosis and finally, the role of melatonin in increasing apoptotic cell death in cancer cells. The mechanisms whereby melatonin influences apoptosis have not clarified, although a number of mechanistic options have been suggested. Apoptotic cell death is a physiological phenomenon related to homeostasis and proper functioning of tissues and organs; however, a failure in the apoptotic program is related to a number of diseases. The participation of melatonin in apoptosis in numerous cell types and its potential importance in a variety of diseases such as immunodeficiency, neurodegeneration and cancer is summarized in this review.
引用
收藏
页码:1407 / 1426
页数:20
相关论文
共 200 条
[71]   Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures [J].
Harms, C ;
Lautenschlager, M ;
Bergk, A ;
Freyer, D ;
Weih, M ;
Dirnagl, U ;
Weber, JR ;
Hörtnagl, H .
FASEB JOURNAL, 2000, 14 (12) :1814-1824
[72]   Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease [J].
Hartmann, A ;
Hunot, S ;
Michel, PP ;
Muriel, MP ;
Vyas, S ;
Faucheux, BA ;
Mouatt-Prigent, A ;
Turmel, H ;
Srinivasan, A ;
Ruberg, M ;
Evan, GI ;
Agid, Y ;
Hirsch, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2875-2880
[73]  
HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627
[74]   The biochemistry of apoptosis [J].
Hengartner, MO .
NATURE, 2000, 407 (6805) :770-776
[75]  
HILL SM, 1988, CANCER RES, V48, P6121
[76]   TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways [J].
Hsu, HL ;
Shu, HB ;
Pan, MG ;
Goeddel, DV .
CELL, 1996, 84 (02) :299-308
[77]   Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture [J].
Iacovitti, L ;
Stull, ND ;
Mishizen, A .
BRAIN RESEARCH, 1999, 816 (02) :276-285
[78]   Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats [J].
Jahnke, G ;
Marr, M ;
Myers, C ;
Wilson, R ;
Travlos, G ;
Price, C .
TOXICOLOGICAL SCIENCES, 1999, 50 (02) :271-279
[79]   Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders [J].
Jan, JE ;
Hamilton, D ;
Seward, N ;
Fast, DK ;
Freeman, RD ;
Laudon, M .
JOURNAL OF PINEAL RESEARCH, 2000, 29 (01) :34-39
[80]  
JANKOVIC BD, 1970, IMMUNOLOGY, V18, P1